Sutro Biopharma, Inc.
STROBiotechnology
$9.14−1.61%As of Oct 29vs prior close
- Market cap
- $151.6M
- P/E (TTM)
- –
- From 52W high
- −77.66%
- EPS (LTM)
- -$17.33
- Revenue (LTM)
- $45.7M
- Net margin
- -395.25%
- Dividend yield
- 0.00%
Nomior Score
33
Steady ProfileSpeculativeBottom 19% of the scored universe
Growth34
Quality34
Value—
Momentum61
Resilience25
Growth
+6.18%revenue a year over 9 fiscal years
YE16 $59.7MLTM $45.7M
Connections
Revenue to profitQ2 YE26
The operating loss was 304% of revenue, wider by 299 pts on a year.
Who owns it
2funds